data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
ChemoCentryx
(NASDAQ:CCXI)
26.15
-1.36[-4.94%]
At close: Jun 24
26.15
00
After Hours: 4:02PM EDT
Day High/Low25.13 - 27.79
52 Week High/Low12.71 - 42.16
Open / Close27.77 / 26.15
Float / Outstanding57.5M / 71.2M
Vol / Avg.2.3M / 1.4M
Mkt Cap1.9B
P/E-
50d Avg. Price21.46
Div / Yield-
Payout Ratio-
EPS-0.55
Total Float57.5M

ChemoCentryx (NASDAQ:CCXI), Quotes and News Summary

ChemoCentryx (NASDAQ: CCXI)

Day High/Low25.13 - 27.79
52 Week High/Low12.71 - 42.16
Open / Close27.77 / 26.15
Float / Outstanding57.5M / 71.2M
Vol / Avg.2.3M / 1.4M
Mkt Cap1.9B
P/E-
50d Avg. Price21.46
Div / Yield-
Payout Ratio-
EPS-0.55
Total Float57.5M
Benzinga - Jun 6, 2022, 8:36AM
Benzinga - May 18, 2022, 8:33AM
Benzinga - May 10, 2022, 12:39PM
Benzinga - May 6, 2022, 11:07AM
Benzinga - May 6, 2022, 8:56AM
Benzinga - May 6, 2022, 8:00AM
Benzinga - May 5, 2022, 6:03PM
Benzinga - Apr 13, 2022, 10:33AM
Benzinga - Apr 13, 2022, 8:32AM
Benzinga - Mar 2, 2022, 1:51PM
Benzinga - Mar 2, 2022, 8:31AM
Benzinga - Mar 2, 2022, 7:54AM
Benzinga - Mar 1, 2022, 4:54PM
Benzinga - Mar 1, 2022, 4:45PM
load more
Sector: Health Care.Industry: Biotechnology
ChemoCentryx Inc is a biopharmaceutical company involved in the discovery, development, and commercialization of orally administered drugs to treat rare diseases, inflammatory disorders, autoimmune diseases, and cancer. The company's approach is to target the chemoattractant system, defined as a network of molecules (for example, chemokine ligands, their associated receptors, and chemoattractant receptors) known to cause inflammation. The targeted therapeutic areas are an antineutrophil cytoplasmic antibody, atypical hemolytic uremic syndrome, immunoglobulin A-mediated nephropathy (rare diseases category), pancreatic cancer, chronic kidney disease, psoriasis, rheumatoid arthritis, asthma, Crohn's disease, inflammatory bowel disease, and others.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-08
REV
Q1 2022Est.ActualSurprise
EPS-0.300-0.550 -0.2500
REV22.040M5.459M-16.581M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

ChemoCentryx Questions & Answers

Q
How do I buy ChemoCentryx (CCXI) stock?
A

You can purchase shares of ChemoCentryx (NASDAQ: CCXI) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are ChemoCentryx's (CCXI) competitors?
Q
What is the target price for ChemoCentryx (CCXI) stock?
A

The latest price target for ChemoCentryx (NASDAQ: CCXI) was reported by Raymond James on Friday, May 6, 2022. The analyst firm set a price target for 106.00 expecting CCXI to rise to within 12 months (a possible 305.35% upside). 7 analyst firms have reported ratings in the last year.

Q
Current Stock Price for ChemoCentryx (CCXI)?
A

The stock price for ChemoCentryx (NASDAQ: CCXI) is $26.15 last updated June 24, 2022, 8:00 PM UTC.

Q
Does ChemoCentryx (CCXI) pay a dividend?
A

There are no upcoming dividends for ChemoCentryx.

Q
When is ChemoCentryx (NASDAQ:CCXI) reporting earnings?
A

ChemoCentryx’s Q2 earnings are confirmed for Monday, August 8, 2022.

Q
Is ChemoCentryx (CCXI) going to split?
A

There is no upcoming split for ChemoCentryx.

Q
What sector and industry does ChemoCentryx (CCXI) operate in?
A

ChemoCentryx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.